https://www.indianpharmapost.com/mercks-pembrolizumab-plus-chemotherapy-showed-sustained-survival-benefit-versus-chemotherapy-alone-129962022-09-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-and-eisai-present-results-from-phase-3-leap-002-trial-evaluating-keytruda-129972022-09-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/thalassemia-sickle-cell-society-receives-200000th-blood-units-129982022-09-12T00:00:00+05:30always0.9https://www.indianpharmapost.com/zenara-pharma-launches-the-first-generic-of-paxlovid-for-covid-19-in-india-129992022-09-12T00:00:00+05:30always0.9